# Musculoskeletal system - BNF Chapter 10

Source: https://www.rightdecisions.scot.nhs.uk/dgrefhelp-nhs-dumfries-galloway/dg-formulary/musculoskeletal-system-bnf-chapter-10/
Fetched: 2026-02-23

## 1. Arthritis

Please refer to the following protocols and guidance:

- NICE guideline NG100: Rheumatoid arthritis in adults: management
- NICE guideline NG65: Spondyloarthritis in over 16s: diagnosis and management

For DMARD monitoring protocols please refer to: DGRefHelp>Rheumatology>DMARD monitoring protocols

Safety considerations

- MHRA: Methotrexate once-weekly for autoimmune diseases: new measures to reduce risk of fatal overdose due to inadvertent daily instead of weekly dosing
- MHRA: Mycophenolate mofetil, mycophenolic acid: updated contraception advice for male patients Feb 2018
- MHRA: Mycophenolate mofetil, mycophenolic acid: new pregnancy-prevention advice for women and men Dec 2015
- MHRA DSU: Mycophenolate mofetil: pure red cell aplasia, July 2009
- MHRA DSU: Mycophenolate mofetil (CellCept) and mycophenolic acid: risk of hypogammaglobulinaemia and risk of bronchiectasis, January 2015
- MHRA DSU: Baricitinib (Olumiant▼): increased risk of diverticulitis, particularly in patients with risk factors
- MHRA DSU tofacitinib-new measures to minimise risk of major adverse cardiovascular events and malignancies October 2021

### Rheumatoid arthritis – moderate to severe disease

#### Immunosuppressants - *Specialist Initiation Only*

#### DMARDs (all initiated in consultation with a specialist)

- Methotrexate ✓ Specialist Initiation Only (2.5mg tablets,once dose is stabilised, specialists may change to once weekly subcutaneous injection pre-filled pens (Metoject®)) Patient should stay on same brand they are used to. Prescribe MTX injection by brand.
- Hydroxychloroquine tablets ✓ Specialist Initiation Only
- Leflunimode tablets ✓ Specialist Initiation Only
- Sulphsalazine EC tablets ✓ Specialist Initiation Only
- Azathioprine tablets ✓ Specialist Initiation Only
- Ciclosporin capsules ✓ Specialist Initiation Only – patients should be maintained on the same brand
- Cyclophosphamide ✓ Specialist Initiation Only

Please note methotrexate should only be prescribed as multiples of the 2.5mg strength tablet once weekly

#### TNF-alpha inhibitors

- Adalimumab SC Injection – preferred biosimilar Amgevita® ✓ Specialist Initiation Only ✓ First Choice
- Infliximab IV/SC Injection - preferred biosimilar Remsima® ✓ Specialist Initiation Only
- Etanercept SC Injection– preferred biosimilar Benepali® ✓ Specialist Initiation Only
- Certolizumab SC Injection ✓ Specialist Initiation Only
- Golimumab SC Injection ✓ Specialist Initiation Only

#### CD-20 blocker

- Rituximab Infusion – preferred biosimilar Ruxience® ✓ Specialist Use Only

#### IL-6 inhibitors

- Sarilumab SC Injection ✓ Specialist Initiation Only
- Tocilizumab SC Injection - preferred biosimilar Tyenne® ✓ Specialist Initiation Only

#### CTLA-4 Blocker

- Abatacept SC Injection ✓ Specialist Initiation Only

#### JAK inhibitors

- Filgotinib tablets ✓ Specialist Initiation Only
- Upadacitinib tablets ✓ Specialist Initiation Only
- Baricitinib tablets ✓ Specialist Initiation Only
- Tofacitinib tablets ✓ Specialist Initiation Only

### Psoriatic Arthritis

#### Immunosuppressants - *Specialist Initiation Only*

#### TNF-alpha inhibitors

- Adalimumab SC Injection – preferred biosimilar Amgevita® ✓ Specialist Initiation Only ✓ First Choice
- Infliximab IV/SC Injection - preferred biosimilar Remsima® ✓ Specialist Initiation Only
- Etanercept SC Injection– preferred biosimilar Benepali® ✓ Specialist Initiation Only
- Certolizumab SC Injection ✓ Specialist Initiation Only
- Golimumab SC Injection ✓ Specialist Initiation Only

#### IL-17 Inhibitors

- Secukinumab SC Injection
- Bimekizumab SC Injection
- Ixekizumab SC Injection

#### IL-12/23 inhibitors

- Ustekinumab SC Injection - preferred biosimilar Uzpruvo® ✓ Specialist Initiation Only
- Guselkumab SC Injection  ✓ Specialist Initiation Only

#### JAK inhibitors

- Upadacitinib tablets ✓ Specialist Initiation Only
- Tofacitinib tablets ✓ Specialist Initiation Only

#### PDE-4 inhibitor

- Apremilast tablets ✓ Specialist Initiation Only

### Ankylosing spondylitis

- Naproxen
- Ibuprofen
- Paracetamol (+/- codeine) where NSAIDs are not suitable/tolerated

#### Immunosuppressants - *Specialist Initiation Only*

#### TNF-alpha inhibitors

- Adalimumab SC Injection – preferred biosimilar Amgevita® ✓ Specialist Initiation Only ✓ First Choice
- Infliximab IV/SC Injection - preferred biosimilar Remsima® ✓ Specialist Initiation Only
- Etanercept SC Injection– preferred biosimilar Benepali® ✓ Specialist Initiation Only
- Certolizumab SC Injection ✓ Specialist Initiation Only
- Golimumab SC Injection ✓ Specialist Initiation Only

#### IL-17 Inhibitors

- Secukinumab SC Injection
- Bimekizumab SC Injection

#### JAK inhibitors

- Upadacitinib tablets ✓ Specialist Initiation Only
- Tofacitinib tablets ✓ Specialist Initiation Only

### Still's disease

- Anakinra SC injection ✓ Specialist Initiation Only as per SMC 2104

### Giant cell arteritis

- Tocilizumab prefilled syringe/pen ✓ Specialist Initiation Only – as per SMC 2014

### ANCA - Associated vasculitis

under specialist management

Induction:

- Glucocorticoids (prednisolone tablets, IV methylprednisolone),
- methotrexate,
- cyclophosphamide,
- Rituximab infusion – preferred biosimilar Ruxience®

Maintenance:

- prednisolone tablets,
- rituxamab infusion – preferred biosimilar Ruxience®,
- azathioprine,
- mycophenolate mofetil,
- methotrexate

## 2. Hyperuricaemia and gout

See:

- DGRefHelp>Rheumatology>Gout
- British society for Rheumatology guidelines for the management of gout 2017
- NICE CKS guidelines https://cks.nice.org.uk/topics/gout/

### Acute attacks

- Naproxen ✓ First Choice
- Ibuprofen
- Colchicine 500mcg tablets BD – QDS

Total dose per course should not exceed 6mg, do not repeat course within 3 days
- Avoid Colchicine in those receiving (or recently prescribed if renal impairment) strong P-glycoprotein or CYP3A4 inhibitors eg clarithromycin. See SPC for colchicine
- MHRA Colchicine: extremely toxic in overdose

### Longterm prophylaxis of gout

- Allopurinol tablets ✓ First Choice
- Febuxostat tablets

## 3. Neuro-muscular disorders

See BNF for further information

- Pyridostigmine tablets ✓ First Choice
- Neostigmine tablets

See BNF for further information

- Baclofen tablets ✓ First Choice
- Diazepam tablets

## 4. Pain and inflammation in musculoskeletal disorders

### Non-steroidal anti-inflammatory drugs

- Naproxen ✓ First Choice
- Ibuprofen

#### Safety considerations

- MHRA: Non-steroidal anti-inflammatory drugs: reminder on renal failure and impairment, May 2009
- MHRA: Non-steroidal anti-inflammatory drugs: cardiovascular risk, October 2012
- MHRA: NSAIDs and coxibs: balancing of cardiovascular and gastrointestinal risks, December 2007 *
- MHRA: Ketoprofen and ketorolac: gastrointestinal risk, December 2014 change to hyperlink

## 5. Soft tissue and joint disorders

### Systemic corticosteroids oral

- Prednisolone tablets ✓ First Choice if prescribing oral steroids please refer to the HIGH DOSE Steroid Pre- treatment checklist in the clinical handbook: https://www.nhsdghandbook.co.uk/medical-handbook/high-dose-steroid-pre-treatment- checklist/?handbook

### Local corticosteroid injections

- Methylprednisolone acetate (Depo – Medrone)
- Triamcinolone acetonide (Kenalog)

### Soft tissue disorders Rubefacients

- Ibuprofen 5%

---
## Editorial Information

- **Last reviewed:** 25/04/2025
- **Next review date:** 30/04/2027
- **Author(s):** Formulary subgroup of ADTC.
- **Version:** 1.0
- **Approved By:** ADTC
